Apparently, apigenin is a multi-targetcompound that triggers breast cancer cell death through the inhibition ofreceptor tyrosine kinases, decreased expression of growth factors, activationof p53, and suppression of key transcription factors. This evidence concerns the gene TP53 and breast carcinoma.